Ranking results:

Past rankings:

2015
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2012
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
Networking Rank (Reputation):	> 1000
2008
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 1
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 1^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2015	0	5.369.886	291.298		1
2012	5.925.462	0	1.341.960	1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
TIGENIX	2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM	1
CENTRE HOSPITALIER UNIVERSITAIRE DE LIMOGES	1
CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS	1
CLINIQUES UNIVERSITAIRES SAINTLUC	1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	1
FARMACROS IBERICA SL	1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	1
MONDRAGON ASSEMBLY SOCIEDAD COOPERATIVA	1
SERVICIO MADRILENO DE SALUD	1
SISTEMIC SCOTLAND LIMITED	1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	1
ZABALA INNOVATION CONSULTING S A	1

Constancy:

Total number of partners: 14
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 14
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2015-11-01	Title of Proposal: Restoring the immune system homeostasis and organ function in severe community acquired pneumonia- induced sepsis through adipose derived allogeneic stem cells (SEPCELL Proje	SEPCELL	participant	5.369.886	6
2012-01-01	Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis	REGENER-AR	coordinator	5.925.462	10

Alias institution names:

TIGENIX NV

TIGENIX NV - Belgium